ArticlePloS one2026
Antioxidant and antibacterial potential of bioactive extraction from Cadaba glandulosa leaves.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the bioactive components and explored the antioxidant and antibacterial properties of the methanolic leaf extracts of Cadaba glandulosa (MLCG). The observed activity is related to the diverse chemical composition of the extract as determined by gas chromatography-mass spectrometry (GC-MS) analysis, which tentatively identified 18 distinct compounds. Notable compounds include methyl dodecanoate, methyl tetradecanoate, 9,12-octadecadienoyl chloride, hexadecanoic acid methyl ester, palmitoleic acid, anethole, brefeldin A and oleic acid. The antioxidant tests showed a significant scavenging activity of 88.2% at a concentration of 381.5 µg/mL, which underlines the effectiveness of the extract in neutralizing free radicals. The total phenolic content in MLCG was found to be 79.5%, corresponding to 250.8 mg of gallic acid equivalents (GAE)/ mL.The antibacterial activity of MLCG showed variability between bacterial strains, with the strongest inhibition observed against Staphylococcus aureus and Streptococcus pyogenes, both Gram-positive bacteria. The extract showed moderate activity against Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa, while the least activity was observed against Klebsiella pneumoniae. In this study, the impressive antioxidant and antibacterial properties of MLCG underline the therapeutic potential of Cadaba glandulosa as a natural source of antioxidant and antibacterial agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.